Angeles Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Sell
916
-35
-4% -$17.9K 0.02% 254
2025
Q4
$534K Buy
951
+32
+3% +$18.2K 0.03% 197
2025
Q3
$473K Buy
919
+11
+1% +$4.8K 0.03% 194
2025
Q2
$285K Sell
908
-23
-2% -$6.91K 0.02% 270
2025
Q1
$284K Buy
931
+1
+0.1% +$336 0.02% 227
2024
Q4
$309K Buy
930
+17
+2% +$5.76K 0.03% 205
2024
Q3
$305K Buy
+913
New +$347K 0.03% 198

Other funds holding MEDP

Angeles Wealth Management's MEDP Position: Q1 2026 in Review

Angeles Wealth Management reduced its Medpace (MEDP) stake by 3.7% in Q1 2026, selling an estimated $17.9K and leaving 916 shares worth $440K. The position accounts for 0.02% of the portfolio, ranked #254.

Angeles Wealth Management first reported a position in MEDP in Q3 2024 and has held it in 7 quarters since. The position peaked at $534K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Angeles Wealth Management held 916 shares of Medpace worth $440K as of Q1 2026.
  • Angeles Wealth Management sold 35 Medpace shares in Q1 2026, an estimated $17.9K.
  • Medpace made up 0.02% of Angeles Wealth Management's portfolio in Q1 2026, its #254 holding.
  • Angeles Wealth Management first reported a position in Medpace in Q3 2024 and has held it in 7 quarters since.
  • Angeles Wealth Management's Medpace position peaked at $534K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.